OECD Series on Adverse Outcome Pathways / OECD Publishing
Citation Profile [Updated: 2024-11-03 20:16:59]
5 Years H Index
1
Impact Factor (IF)
0.09
5 Years IF
0.05
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2016 | 0 | 0.64 | 0 | 0 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.34 | |||||
| 2018 | 0 | 0.61 | 0 | 0 | 4 | 8 | 0 | 0 | 4 | 4 | 0 | 0 | 0.34 | |||||
| 2019 | 0 | 0.62 | 0 | 0 | 6 | 14 | 0 | 0 | 4 | 8 | 0 | 0 | 0.36 | |||||
| 2021 | 0 | 0.95 | 0 | 0 | 3 | 17 | 0 | 0 | 6 | 14 | 0 | 0 | 0.39 | |||||
| 2022 | 0 | 0.69 | 0 | 0 | 8 | 25 | 0 | 0 | 3 | 13 | 0 | 0 | 0.22 | |||||
| 2023 | 0.09 | 0.59 | 0.03 | 0.05 | 7 | 32 | 0 | 1 | 1 | 11 | 1 | 21 | 1 | 0 | 0 | 0.18 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2021 | Adverse Outcome Pathway on Cyp2E1 activation leading to liver cancer. (2021). Yauk, Carole L ; Lambert, Iain B ; Webster, Francina. In: OECD Series on Adverse Outcome Pathways. RePEc:oec:envaad:19-en. Full description at Econpapers || Download paper | 1 |
| 2 | Adverse Outcome Pathway on Inhibition of the mitochondrial complex I of nigro-striatal neurons leading to parkinsonian motor deficits. (2018). Bal-Price, Anna ; Terron, Andrea ; Paini, Alicia ; Tschudi-Monnet, Florianne ; Schildknecht, Stefan ; Leist, Marcel. In: OECD Series on Adverse Outcome Pathways. RePEc:oec:envaad:7-en. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|
Citing documents used to
compute impact factor: 1
| Year | Title | |
|---|---|---|
| 2023 | . Full description at Econpapers || Download paper |
Recent citations